logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Krishan, Kewal Singh, Dr

    Related profiles found in government register
  • Krishan, Kewal Singh, Dr
    British

    Registered addresses and corresponding companies
    • 7, Bell Yard, London, WC2A 2JR, United Kingdom

      IIF 1
  • Krishan, Kewal Singh, Dr
    British director

    Registered addresses and corresponding companies
    • 95, Wrottesley Road, Wolverhampton, WV6 8SQ, United Kingdom

      IIF 2
  • Krishan, Kewal Singh

    Registered addresses and corresponding companies
    • 95, Wrottesley Road, Wolverhampton, WV6 8SQ, United Kingdom

      IIF 3
  • Krishan, Kewal Singh, Dr
    British born in December 1954

    Resident in United Kingdom

    Registered addresses and corresponding companies
    • 7, Bell Yard, London, WC2A 2JR, United Kingdom

      IIF 4 IIF 5 IIF 6
    • Pennfields Medical Centre, Upper Zoar Street, Wolverhampton, WV3 0JH, England

      IIF 8
  • Krishan, Kewal Singh, Dr
    British director born in December 1954

    Resident in United Kingdom

    Registered addresses and corresponding companies
    • 7, Bell Yard, London, WC2A 2JR, United Kingdom

      IIF 9
  • Dr Kewal Singh Krishan
    British born in December 1954

    Resident in England

    Registered addresses and corresponding companies
    • 7, Bell Yard, London, WC2A 2JR, United Kingdom

      IIF 10 IIF 11 IIF 12
    • 95, Wrottesley Road, Wolverhampton, WV6 8SQ, United Kingdom

      IIF 13
  • Dr Kewal Singh Krishan
    British born in December 1954

    Resident in United Kingdom

    Registered addresses and corresponding companies
    • 7, Bell Yard, London, WC2A 2JR, United Kingdom

      IIF 14
child relation
Offspring entities and appointments
Active 6
  • 1
    SUKH PROPERTIES LTD - 2020-03-24
    7 Bell Yard, London, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    1,406,933 GBP2024-12-31
    Officer
    2016-09-22 ~ now
    IIF 5 - Director → ME
    Person with significant control
    2018-12-12 ~ now
    IIF 12 - Ownership of shares – More than 25% but not more than 50%OE
    IIF 12 - Ownership of voting rights - More than 25% but not more than 50%OE
  • 2
    GRACFIELD DEVELOPMENTS LTD - 2005-12-05
    7 Bell Yard, London, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    -886,998 GBP2024-12-31
    Officer
    2005-11-20 ~ now
    IIF 7 - Director → ME
    2005-11-20 ~ now
    IIF 1 - Secretary → ME
  • 3
    MAYFIELD PHARMACY LTD - 2008-11-03
    7 Bell Yard, London, United Kingdom
    Active Corporate (5 parents)
    Equity (Company account)
    128,967 GBP2024-12-31
    Officer
    2008-12-05 ~ now
    IIF 4 - Director → ME
  • 4
    7 Bell Yard, London, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    120 GBP2024-12-31
    Officer
    2021-10-05 ~ now
    IIF 6 - Director → ME
    Person with significant control
    2021-10-05 ~ now
    IIF 14 - Ownership of shares – More than 25% but not more than 50%OE
    IIF 14 - Ownership of voting rights - More than 25% but not more than 50%OE
  • 5
    PREMIER MEDICAL PROPERTIES LIMITED - 2020-05-11
    PREMIER MEDICAL PROPERTY LIMITED - 2002-06-02
    7 Bell Yard, London, United Kingdom
    Liquidation Corporate (4 parents)
    Equity (Company account)
    1,539,691 GBP2023-12-31
    Officer
    2002-04-10 ~ now
    IIF 9 - Director → ME
    Person with significant control
    2016-04-06 ~ now
    IIF 10 - Ownership of shares – More than 25% but not more than 50%OE
    IIF 10 - Ownership of voting rights - More than 25% but not more than 50%OE
  • 6
    Pennfields Medical Centre, Upper Zoar Street, Wolverhampton, England
    Active Corporate (7 parents)
    Equity (Company account)
    525,193 GBP2024-03-31
    Officer
    2019-06-26 ~ now
    IIF 8 - Director → ME
Ceased 3
  • 1
    SUKH PROPERTIES LTD - 2020-03-24
    7 Bell Yard, London, United Kingdom
    Active Corporate (4 parents)
    Equity (Company account)
    1,406,933 GBP2024-12-31
    Person with significant control
    2016-09-22 ~ 2017-04-28
    IIF 13 - Ownership of shares – More than 25% but not more than 50% OE
    IIF 13 - Ownership of voting rights - More than 25% but not more than 50% OE
  • 2
    MAYFIELD PHARMACY LTD - 2008-11-03
    7 Bell Yard, London, United Kingdom
    Active Corporate (5 parents)
    Equity (Company account)
    128,967 GBP2024-12-31
    Officer
    2008-08-04 ~ 2018-09-11
    IIF 3 - Secretary → ME
    Person with significant control
    2016-04-06 ~ 2024-10-22
    IIF 11 - Ownership of shares – More than 25% but not more than 50% OE
    IIF 11 - Ownership of voting rights - More than 25% but not more than 50% OE
  • 3
    PREMIER MEDICAL PROPERTIES LIMITED - 2020-05-11
    PREMIER MEDICAL PROPERTY LIMITED - 2002-06-02
    7 Bell Yard, London, United Kingdom
    Liquidation Corporate (4 parents)
    Equity (Company account)
    1,539,691 GBP2023-12-31
    Officer
    2002-04-10 ~ 2018-09-11
    IIF 2 - Secretary → ME

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.